Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;23(4):259–263. doi: 10.1002/clc.4960230407

Plasma big‐endothelin levels, cardiac autonomic neuropathy, and cardiac functions in patients with insulin‐dependent diabetes mellitus

Tomris Erbas 1,, Olcay Gedik 1, Zehra Koray 2, Belkis Erbas 2, Giray Kabakci 3, Serdar Aksöyek 3
PMCID: PMC6655115  PMID: 10763073

Abstract

Background: The alteration of endothelin (ET) levels in diabetic patients with cardiac autonomic neuropathy (CAN) has not been studied extensively and its correlation with cardiac function parameters has not been discussed.

Hypothesis: The aim of the present study was to discuss the correlation between the degree of cardiac autonomic neuropathy, plasma big‐ET levels, and cardiac functions in diabetic patients who were clinically free of cardiovascular disease.

Methods: Twenty subjects (32.1 ± 7.8 years, 11 men, 9 women) with insulin‐dependent diabetes mellitus (IDDM) were studied to evaluate the relationship between circulating big‐endothelin (big‐ET1) levels, CAN, and cardiac functions. The severity of CAN was scored according to Ewing's criteria. Cardiac functions were assessed using Doppler echocardiography.

Results: Left ventricular systolic function in the patient group was within normal limits and comparable with the values of the control group (n = 10). The mean E/A values of diabetics with CAN (1.15 ± 0.33, p = 0.004) and without CAN (1.34 ± 0.17) were significantly lower than those of controls (1.57 ± 0.27). Diabetics with CAN had significantly higher big‐ET1 values (81.1 ± 94 pg/ml) compared with others (12.4 ± 5.9 and 21.1 ± 17.7 pg/ml, p = 0.04). Circulating big‐ET1 levels showed a significant correlation with E/A values in the control group (p = 0.01, r = ‐ 0.7) and with peak A values (p = 0.003, r = 0.64) in diabetics. The CAN score correlated negatively with E/A values (p = 0.01, r = 0.54).

Conclusions: High big‐ET levels might have an important role in the pathogenesis or consequences of diastolic dysfunction in diabetics with CAN. Their role in cardiac autonomic neuropathy and diastolic dysfunction should be investigated further.

Keywords: diabetes mellitus, endothelin, cardiac autonomic neuropathy, cardiac functions

Full Text

The Full Text of this article is available as a PDF (498.3 KB).

References

  • 1. Little WC, Downes TR: Clinical evaluations of left ventricular diastolic performance. Prog Cardiovasc Dis 1990; 32: 273–290 [DOI] [PubMed] [Google Scholar]
  • 2. Erbas T, Erbas B, Gedik O, Biberoglu S, Bekdik CF: Scintigraphic evaluation of left ventricular function and correlation with autonomic cardiac neuropathy in diabetic patients. Cardiology 1992; 8: 14–24 [DOI] [PubMed] [Google Scholar]
  • 3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415 [DOI] [PubMed] [Google Scholar]
  • 4. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306–310 [DOI] [PubMed] [Google Scholar]
  • 5. Kanno K, Hirata Y, Shichiri M, Marumo F: Plasma endothelin‐1 levels in patients with diabetes mellitus with or without vascular complication. J Cardiovasc Pharmacol 1991; 17 (suppl): S 475–476 [DOI] [PubMed] [Google Scholar]
  • 6. Collier A, Leach JP, McLellen A, Jardine A, Morton JJ, Small M: Plasma endothelin like immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 1992; 15: 1038–1040 [DOI] [PubMed] [Google Scholar]
  • 7. Kawamura M, Ohgawara H, Naruse M, Suzuki N, Iwasaki N, Naruse K: Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 1992; 15: 1396–1397 [DOI] [PubMed] [Google Scholar]
  • 8. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T: Positive chronotropic effects of endothelin, a novel endothelium‐derived vasoconstrictor peptide. Pflegers Arch 1988; 423: 108–110 [DOI] [PubMed] [Google Scholar]
  • 9. Gu XH, Casley D, Nayler W: Specific high‐affinity binding sites for 1251‐labelled porcine endothelin in rat cardiac membranes. Eur J Pharmacol 1989; 67: 281–290 [DOI] [PubMed] [Google Scholar]
  • 10. Galron R, Kloog Y, Bdolah A, Sokolovsky M: Functional endothelin/sarafotoxin receptors in rat heart myocytes: Structure‐activity relationships and receptor subtypes. Biochem Biophys Res Commun 1989; 163: 936–943 [DOI] [PubMed] [Google Scholar]
  • 11. Hirata Y: Endothelin‐1 receptors in cultured vascular smooth muscle cells and cardiocytes of rats. J Cardiovasc Pharmacol 1989; 13: S157–S158 [DOI] [PubMed] [Google Scholar]
  • 12. Ewing DJ, Campbell IW, Clake BF: The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49: 95–108 [PubMed] [Google Scholar]
  • 13. Sahn DJ, De Maria A, Kisslo J, Weyman A: The committee on M‐mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M‐mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083 [DOI] [PubMed] [Google Scholar]
  • 14. Riggs TW, Transue D: Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol 1990; 65: 899–902 [DOI] [PubMed] [Google Scholar]
  • 15. Sampson MJ, Chambers JB, Sprigings DC, Drury PL: Abnormal diastolic function in patients with type I diabetes and early nephropathy. Br Heart J 1990; 64: 266–271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Smulders RA, Stehouwer CDA, Olrhof GC, van Kamp GJ, Doker AJM: Plasma endothelin levels and vascular effects of L‐arginine in type 1‐insulin dependent diabetes. Diabetologia 1992; 35 (suppl 1): A 19 1541376 [Google Scholar]
  • 17. Polderman KH, Stehouwer CDA, van Kamp GJ, Dekker GA, Verheught FWA, Gooren LJG: Influence of sex hormones on plasma levels of endothelin. Ann Intern Med 1993; 86: 429–432 [DOI] [PubMed] [Google Scholar]
  • 18. Tsunado K, Abe K, Yoshinga K: Supressed conversion of big‐endothelin to endothelin‐1 in patients with diabetes mellitus. J Hypertens 1992; 10 (suppl 4): S99 [Google Scholar]
  • 19. Hu RM, Levin ER, Pedram A, Frank HJL: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993; 42: 351–358 [DOI] [PubMed] [Google Scholar]
  • 20. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Newata H: Enhanced secretion of endothelin‐1 by elevated glucose levels from cultured bovine aortic cells. FEBS Lett 1990; 267: 16–18 [DOI] [PubMed] [Google Scholar]
  • 21. Kramer BK, Smith TW, Kelly RA: Endothelin and increased contractility in adult ventricular myocytes. Circ Res 1991; 68: 269–279 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES